Levosalbutamol and Ipratropium Bromide Respiratory Solution

Levosalbutamol and Ipratropium Bromide Respiratory Solution

R.S. IPRATROP 1.25  is a medication used primarily to treat symptoms of chronic obstructive pulmonary disease (COPD) and asthma. It is a combination of two medications - levosalbutamol and ipratropium bromide - that work together to improve breathing and reduce symptoms such as coughing, wheezing, and shortness of breath.
Levosalbutamol is a bronchodilator that works by relaxing the muscles in the airways and improving airflow to the lungs. Ipratropium bromide is an anticholinergic medication that works by blocking certain chemicals that cause the airways to narrow, thereby improving breathing.
R.S. IPRATROP 1.25 is usually taken by inhalation using a nebulizer, a machine that converts the medication into a fine mist that can be breathed in. R.S. IPRATROP 1.25  dosage and frequency of use will depend on the condition being treated and the individual's response to the medication. R.S. IPRATROP 1.25  is important to follow the dosage instructions provided by a healthcare professional and to use the nebulizer properly to ensure optimal delivery of the medication.
Like all medications, R.S. IPRATROP 1.25  may cause side effects, including headache, dizziness, dry mouth, and throat irritation. It may also interact with other medications, so it is important to inform a healthcare professional of all medications being taken.
R.S. IPRATROP 1.25  is not recommended for use in individuals with certain medical conditions, such as a history of narrow-angle glaucoma or an allergy to any of the ingredients in the medication. Therefore, it is important to inform a healthcare professional of any medical conditions before using this medication.
For further information please contact:
info@sterispharma.com